Predictors of early mortality after transjugular intrahepatic portosystemic shunt creation for the treatment of refractory ascites

Journal of Vascular and Interventional Radiology

Volumn 17, Issue 10, 2006, Pages 1605-1610

  Harrod Kim, Paul ^a   Saad, Wael ^a   Waldman, David ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASCITES; EMERGENCY CARE; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; LIVER CIRRHOSIS; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVORS; TIME FACTORS;

EID: 33750036983     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000240651.38289.4B     Document Type: Article

References (23)

1. Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996; 23:164-176.
2. Bosch J, Garcia-Pagan JC. Complications of cirrhosis. I: portal hypertension. J Hepatol 2000; 32:141-146.
3. Runyon BA. Refractory ascites. Semin Liver Dis 1993; 13:343-351.
4. Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites and spontaneous bacterial peritonitis. Gastroenterology 2001; 120:726-748.
5. Ochs A, Rossle M, Haag K, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995; 332:1192-1197.
6. Quiroga J, Sangro B, Nunez M, et al. Transjugular intrahepatic portosystemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral and hemodynamic parameters. Hepatology 1995; 21:986-994.
7. D'Amico G, Luca A, Morabito A, et al. Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis. Gastroenterology 2005; 129:1282-1293.
8. Albillos A, Banares R, Gonzalez M, et al. A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites. J Hepatol 2005; 43:990-996.
9. Boyer TD, Haskal ZJ. American Association for the Study of Liver Diseases practice guidelines: the role of transjugular intrahepatic portosystemic shunt creation in the management of portal hypertension. J Vasc Interv Radiol 2005; 16:615-629.
10. Rector WG Jr. Portal hypertension: a permissive factor only in the development of ascites and variceal bleeding. Liver 1986; 6:221-226.
11. Kanterman RY, Darcy MD, Middletone WD, et al. Doppler sonography findings associated with transjugular intrahepatic portosystemic shunt malfunction. AJR Am J Roentgenol 1997; 168:467-472.
12. Lebrec D, Giuily N, Hadengue A, et al. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. J Hepatol 1996; 25:135-144.
13. Rossle M, Ochs A, Gulberg V, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000; 342:1701-1707.
14. Gines P, Urz J, Calahorra B, et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002; 123:1839-1847.
15. Sanyal AJ, Genning C, Reddy KR, et al. The North American study for the treatment of refractory ascites. Gastroenterology 2003; 124:634-641.
16. Salerno F, Merli M, Riggio O, et al. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology 2004; 40:629-635.
17. Nair S, Singh R, Yoselewitz M. Correlation between portal/hepatic vein gradient and response to transjugular intrahepatic portosystemic shunt creation in refractory ascites. J Vasc Interv Radiol 2004; 15:1431-1434.
18. Malinchoc M, Kamath P, Gordon F, et al. Model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31:864-871.
19. Shepke M, Roth F, Fimmers R, et al. Comparison of MELD, Child-Pugh and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting. Am J Gastroenterol 2003; 98:1167-1174.
20. Walser E, DeLa Pena R, Villanueva-Meyer J, et al. Hepatic perfusion before and after the transjugular intrahepatic portosystemic shunt procedure: impact on survival. J Vasc Interv Radiol 2000; 11:913-918.
21. Walser E, Ozkan O, Raza S, et al. Hepatic perfusion as a predictor of mortality after transjugular intrahepatic portosystemic shunt creation in patients with refractory ascites. J Vasc Interv Radiol 2003; 14:1251-1257.
22. Harrod-Kim P, Waldman DL. Abnormal portal venous flow at sonography predicts reduced survival after transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol 2005; 16:1459-1464.
23. Van Beers B, Leconte I, Materne R, et al. Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. AJR Am J Roentgenol 2001; 176:667-673.